Bioscience Investment Associate


Wenping is responsible for evaluating biotech company investment opportunities, conducting due diligence and observing portfolio companies. She joined CI as a fresh PhD graduate from Yale University, where she did research examining the biological roots of cardiovascular diseases by using optogenetic, single-cell RNA sequencing, proteomic technologies, etc. During her time at Yale, Wenping also did a pro bono consulting project for a biotech company to identify promising disease areas and part-time internships at Lilly Asia Ventures and Simcere Pharmaceutical Group.